News

e.l.f. Beauty's Market Position: Insights for Investors

e.l.f. Beauty's Market Position: Insights for Investors

e.l.f. Beauty Stock Insights

e.l.f. Beauty (NYSE: ELF) has recently caught the attention of investors, becoming one of the most searched stocks in the market. Understanding the factors affecting its stock performance can provide clarity moving forward.

Performance Overview

In the past month, e.l.f. Beauty's shares have shown a return of -1.9%, while the broader S&P 500 composite has increased by 2%. The overall Zacks Cosmetics industry, where e.l.f. Beauty is categorized, has experienced a more significant drop of 11.2% during the same timeframe. This raises questions about the potential direction of e.l.f. Beauty's stock in the upcoming weeks.

Understanding Earnings Estimates

Earnings estimates are integral to assessing a company's financial health. Analysts adjust these projections based on recent business movements, and e.l.f. Beauty is expected to report earnings of $0.44 per share for the current quarter, marking a decline of 46.3% from the prior year. The consensus for the fiscal year stands at $3.53, reflecting an 11% increase compared to the last fiscal year.

Looking Ahead

As we analyze the projections for the next fiscal year, the consensus estimate increases to $4.42, suggesting a notable growth of 25.3% year-over-year. These figures underline the importance of earnings estimate revisions in painting a clearer picture of the company's future performance.

Revenue Growth Expectations

A company's revenue growth holds significant weight in determining its overall health. For e.l.f. Beauty, expectations for the current quarter project sales of $291.03 million, equivalent to a 35% year-over-year increase. Looking into the fiscal future, sales estimates are set at $1.32 billion and $1.56 billion, denoting yearly increases of 29.2% and 17.9%, respectively.

Analyzing Previous Results

e.l.f. Beauty's recent quarterly report revealed revenues of $324.48 million, showcasing a remarkable year-over-year growth of 50%. Additionally, the company reported earnings per share (EPS) of $1.10, in line with the previous year. These results not only surpassed the Zacks Consensus Estimate of $303.6 million by 6.88% in revenue but also exceeded EPS expectations by 32.53%.

Consistent Performance

e.l.f. Beauty consistently outperformed consensus estimates in both earnings and revenue across the last four quarters, signaling a strong financial positioning that may further bolster investor confidence.

Stock Valuation Insights

Understanding a stock's valuation is crucial before making investment decisions. Evaluating valuation metrics such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF) helps investors gauge whether the share price aligns with the company's underlying business value and growth potential.

Currently, e.l.f. Beauty carries an F rating in Zacks Value Style Score, indicating that it is trading at a premium compared to its peers. This assessment suggests a careful consideration of whether the current stock price justifiably reflects its true value.

Final Thoughts

In summary, these insights provide a comprehensive outlook on e.l.f. Beauty and its standing in a competitive retail environment. These analytical evaluations, combined with the company's Zacks Rank of #3 (Hold), imply a performance in line with the market's movements in the near term.

Frequently Asked Questions

What is the current earnings estimate for e.l.f. Beauty?

The current earnings estimate for e.l.f. Beauty is $0.44 per share, reflecting a year-over-year decline of 46.3%.

How does e.l.f. Beauty's revenue forecast look?

e.l.f. Beauty's revenue forecast for the current quarter is $291.03 million, showing a 35% growth from the previous year.

What is e.l.f. Beauty's valuation rating?

e.l.f. Beauty holds an F rating in Zacks Value Style Score, indicating it is trading at a premium compared to its peers.

Has e.l.f. Beauty consistently exceeded earnings estimates?

Yes, e.l.f. Beauty has surpassed consensus earnings estimates in each of the last four quarters.

What is e.l.f. Beauty's Zacks Rank?

e.l.f. Beauty has a Zacks Rank of #3, suggesting a performance that aligns with the wider market trends.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 4

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 3

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 4

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 5

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 4

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading

Top 5 Most Recently Viewed Articles

Kenco Logistics Reports Significant Sustainability Advances

Updated Category News Views 403

Kenco Logistics Reports Significant Sustainability Advances Kenco, a prominent third-party logistics provider, has made remarkable strides in its sustainability efforts according to its annual Sustainability Report. The report highlights the company’s commitment to Environmental, Social, and Governance (ESG) initiatives, showcasing their dedication to creating safe...

Continue Reading
TerSera's Study Reveals Efficacy of Goserelin for Breast Cancer

Updated Category News Views 179

TerSera's Key Findings on Goserelin for Women with Breast Cancer TerSera Therapeutics LLC has made significant contributions to the understanding of goserelin, an important drug in treating breast cancer, particularly in premenopausal women. They recently presented new analyses demonstrating the effectiveness of goserelin dosages of 3.6 mg and 10.8 mg during a poster...

Continue Reading
NewtekOne, Inc. Elevates Peter Downs to President of Newtek Bank

Updated Category News Views 159

New Leadership at Newtek Bank NewtekOne, Inc. (NASDAQ: NEWT) has exciting news regarding its leadership this year. The company's transformation is marked by the promotion of Peter Downs to President of Newtek Bank, N.A. This decision reflects the company's continued growth and commitment to offering innovative solutions for independent business owners. Peter's extensive...

Continue Reading
HomeTrust Bancshares Transitions to NYSE with New Ticker HTB

Updated Category News Views 139

HomeTrust Bancshares, Inc. Transfers Its Listing to the NYSE HomeTrust Bancshares, Inc. has made a significant move by announcing its transfer of common stock listing from NASDAQ to the New York Stock Exchange (NYSE). This exciting transition highlights the Company’s commitment to growth and its aim to provide its shareholders with enhanced value and visibility. The...

Continue Reading
Ideal Power's New Order Highlights SymCool® IQ Capabilities

Updated Category News Views 309

Innovative Steps for Ideal Power with SymCool® IQ Modules Ideal Power Inc. (NASDAQ: IPWR) has recently announced an exciting multi-unit order for its cutting-edge SymCool® IQ intelligent power module. This order stands as a testament to the company's commitment to delivering innovative solutions in the field of power electronics. With an established reputation for...

Continue Reading